G-CSF-mobilised granulocyte transfusion to an ALL patient complicated by cytomegalovirus transmission

This publication has 10 references indexed in Scilit:

• Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation
  Clinical Infectious Diseases, 2003
• Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation
  Blood, 2003
• Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation
  Bone Marrow Transplantation, 2002
• Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
  Blood, 2002
• Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
  British Journal of Haematology, 1999
• Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions
  Current Opinion in Hematology, 1998
• Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.
  The Journal of Infectious Diseases, 1998
• Laboratory diagnosis of HCMV-related disease in renal transplant patients - pp65 antigen detection versus nested PCR
  Clinical and Diagnostic Virology, 1995
• The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis [see comments]
  Blood, 1993
• Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products.
  Journal of Clinical Pathology, 1985